Document is current
Any future updates will be listed below
-
Authors
Blödt, S.
Erstling, S.
Becker, M.
Carl, G.
Follmann, M.
Frenz, S.
Holmberg, C.
Langer, T.
Pachanov, A.
Pieper, D.
Nothacker, M.
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 9 September 2024
First Online: 9 October 2024
Declarations
:
: No ethical approval was needed for this survey, which used anonymised data in accordance with the Berlin chamber of physicians’ medical code of conduct §15 section 1.Participation in the survey was voluntary and participants gave informed consent before starting the survey.
: Not applicable.
: Susanne Blödt, Monika Nothacker and Sabine Erstling are employed at the Institute for Medical Knowledge Management of the Association of the Scientific Medical Societies in Germany (AWMF-IMWi). The AWMF-IMWi receives institutional third-party funding from the German Cancer Aid for methodological support of the German Guideline Program in Oncology. Markus Follmann and Thomas Langer are employed at the German Cancer Society and are partially funded by the German Cancer Aid for coordinating the GGPO and providing methodological support for the guideline groups developing patent versions. Monika Becker and Dawid Pieper received institutional funding for the development of oncological patient versions of guidelines in Germany. Ernst-Günther Carl, Stefanie Frenz, Christine Holmberg and Alexander Pachanov did not report any competing interests.
